Critical Insights From Travere Therapeutics Analyst Ratings: What You Need To Know
Critical Insights From Travere Therapeutics Analyst Ratings: What You Need To Know
來自Travere Therapeutics分析師評級的關鍵見解：你需要知道的
4 analysts have shared their evaluations of Travere Therapeutics (NASDAQ:TVTX) during the recent three months, expressing a mix of bullish and bearish perspectives.
4位分析師分享了他們最近三個月對Travere Therapeutics（納斯達克股票代碼：TVTX）的評估，表達了看漲和看跌的觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要概述了他們最近的評級，重點介紹了過去30天中情緒的變化，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Travere Therapeutics, revealing an average target of $13.0, a high estimate of $17.00, and a low estimate of $9.00. This current average reflects an increase of 4.0% from the previous average price target of $12.50.
分析師已經爲Travere Therapeutics設定了12個月的目標股價，顯示平均目標股價爲13.0美元，最高估計爲17.00美元，低估值爲9.00美元。目前的平均價格比之前的平均目標價12.50美元增長了4.0％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
The analysis of recent analyst actions sheds light...
對分析師最近行爲...
登入免費觀看全文
登入/註冊